Grifols works each and every day to improve the health and well-being of people around the world. It's been this way since 1909, when the company's founder, Josep Antoni Grifols i Roig, established our ongoing commitment to generate positive social impact through research and innovation, striving to create a better society for all. Enveloped in the company's history are the principles of integrity, ethics, honesty and transparency.
“The right to live in society entails the duty to work to improve it.”
Inspired by our values, we are determined to safeguard human rights by identifying, preventing, mitigating and addressing any adverse effects on people that could arise directly or indirectly from the company's business activities. Please see our Human Rights Policy for more information.
Grifols partners with public, public-private, academic and civil-society organizations that share our commitment to improving access to health, protecting the environment and promoting the research and development of new therapeutics that enhance people's health and quality of life.
We're proud that our daily work helps society, generating local jobs and social value for donors, patients and communities. At the same time, we take care so that our operations leave a soft environmental footprint. The company applies ecoefficient and circular economy measures to our products, processes and facilities.
We have developed a Sustainability Master Plan that seeks to consolidate and reinforce our sustainable culture throughout the company. This plan is in alignment with the Sustainable Development Goals (SDGs) set out in the United Nations (UN) 2030 Agenda.
We joined the UN's plan and established priority corporate goals, aligned with the SDGs, to contribute to reduce inequalities and promote global prosperity through economic growth, social inclusion and environmental protection.
In 2021, we reinforced our commitment sustainability by signing the UN Global Compact, a global initiative that calls on companies to align their operations with the universal principles of human rights, labor, environment and anti-corruption. As a participant, Grifols reports its progress towards UN’s SDGs.
Our approach to sustainable value creation is internationally recognized. In 2024, Grifols ranked as the number one biotechnology company in the Dow Jones Best-in-Class Indices (formerly DJSI), after being included in the Dow Jones Best-in-Class World Index and Dow Jones Best-in-Class Europe Index (formerly DJSI World and DJSI Europe) for the fourth and fifth consecutive years, respectively.
In addition, in 2024, the company obtained the EcoVadis Gold Medal for the second consecutive year and the Prime badge in the ISS ESG corporate rating. Grifols also received a BBB rating in the MSCI ESG Ratings assessment and is one of the top-rated companies by Sustainalytics with a low ESG risk rating.
Furthermore, Grifols participates annually in the Carbon Disclosure Project (CDP) and, since 2018, Grifols has been a constituent of the FTSE4Good Index which identifies companies that demonstrate strong ESG practices measured according to globally recognized standards.
Commitment to donors and patients
Patients and donors inspire us every day to achieve our mission.
Impact on society
Grifols, we are people helping people. Each of us contributes to improving people's health and well-being.
Our people
Our employees are our greatest asset. We ensure their health, safety and well-being in diverse and inclusive environments.
The environment
We are mindful stewards of the environment and contribute to fight climate change.
Ethical leadership
Our core values and ethical standards form part of our DNA. At Grifols, our sustainable business model is based on continuous innovation, quality, safety and ethical leadership.
Sustainability Reports
We publish detailed information on our financial and operational performance, innovation, corporate governance, and environmental and social stewardship.
Grifols ranked number one biotech company in Dow Jones Sustainability Indices
Grifols awarded Gold Medal by EcoVadis for Sustainability Excellence
Grifols receives SBTi approval for its near-term science-based emission reduction targets